The Pfizer China R&D Center (CRDC) located in Zhangjiang Hi-Tech Park is an important R&D center of Pfizer in the Asia-Pacific region, providing support services for Pfizer's global R&D projects in the fields of biology, chemistry and pharmacy.
In addition to activities related to drug development, the center also has an Asian research team to implement and coordinate Pfizer's Asian research strategy, and cooperate with academic research institutions, clinical experimental institutions (CRO) and government research institutions all over Asia to enhance research capabilities in Asia.
Development history:
Pfizer always regards "creating a healthy China" as its mission in China, and promises to actively participate in promoting the development of medical and health undertakings in China and improving people's health. We aim to meet the diversified medical service needs of 654.38+300 million people in China through innovative, socially responsible and commercially feasible ways.
In addition to providing a wide range of innovative medical and health products, Pfizer also actively cooperates with relevant government departments, scientific research/medical institutions, academic organizations and social organizations, and actively promotes the development of medical and health undertakings in China by carrying out projects such as patient education, disease promotion, health management, community medical care and personnel training.